- Telehealth Visits
- Insurance plan information
Yanett Anaya, MD
Reproductive Endocrinology and Infertility- Telehealth Visits
- Insurance plan information
Yanett Anaya, MD
Reproductive Endocrinology and Infertility- Telehealth Visits
- Insurance plan information
On this page
About me
Education & training
Board certification
- Reproductive Endo/Infertility, American Board of Obstetrics and Gynecology
- Obstetrics & Gynecology, American Board of Obstetrics and Gynecology
Fellowship
- Reproductive Endocrinology & Infertility, UCSF Graduate Medical Education
Residency
- Obstetrics & Gynecology, Baylor College of Medicine OB/GYN Residency
Degree
- MD, University of Texas at San Antonio
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%222141%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%222141%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Showing 1-6 of 25 reviews
- January 23, 20265 out of 5 Stars
Dr. Anaya is the best doctor I have ever encountered in my life. She listens, doesn't judge, doesn't rush, and most importantly cares. She is a gem and we would be lost without out her. Im so grateful that I am her patients and in her hands for my care.
- January 23, 20265 out of 5 Stars
Dr Anaya was outstanding, as usual. We're grateful to have her as our provider.
- November 5, 20250 out of 5 Stars
Very good
- September 19, 20253 out of 5 Stars
Provider began with explanations before learning I had undergone egg freezing previously.
- August 5, 20255 out of 5 Stars
100% would recommend my provider and team to anyone who needs similar care.
- July 24, 20255 out of 5 Stars
Outstanding provider
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.